ArticleEBioMedicine2026

A multi-centre, phase 1a/1b dose escalation and expansion study of the HER2-directed antibody-drug conjugate T-Bren (BL-M07D1) in advanced breast cancer and other solid tumours.

Herui Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.